FDA Approves Actavis Drug in Treating cUTI and cIAI

An advisory for the FDA has given the greenlight on a new investigational drug for helping in treating two infections triggered as a result of pathogens which are resitant to other drugs.

The company Actavis announced on 5th of December that the advisory committee which advises the FDA agreed on recommending the FDA about the approval of the drug ceftazidime-avibactam for the treatment of complicated UTIs (Urinary Tract Infections), in combination with the antibiotic metronidazole in...